adenosine has been researched along with Carcinoma, Pancreatic Ductal in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 8 (72.73) | 2.80 |
Authors | Studies |
---|---|
Bailey-Lundberg, JM; Bar-Sagi, D; Brown, PH; Bynon, JS; Chandra, V; Clark, T; Dai, Y; Eltzschig, HK; Faraoni, EY; Le Roux, O; Li, L; McAllister, F; Mills, T; Mohammed, A; O'Brien, BJ; Poulsen, KL; Pruski, M; Sahin, I; Savage, MI; Sei, S; Singh, K; Strickland, LN; Thosani, NC; Van Buren, G; Vornik, LA; Vucic, E; Warner, AN; Wray, CJ; Zhao, Z | 1 |
Guo, Z; Huang, Y; Lai, S; Li, T; Lin, C; Wang, Y; Weng, S; Zhang, X | 1 |
Hu, L; Jiang, S; Li, B; Li, R; Zhang, X; Zhang, Y; Zhang, Z; Zhu, L | 1 |
Brais, R; Buckley, H; Dannhorn, A; Dovedi, SJ; Eyles, J; Goodwin, R; Graziano, V; Hulme, H; Islam, S; Jodrell, DI; Kaistha, BP; Karim, SA; Lee, SY; Morton, JP; Richards, FM; Schuller, AG; Thaventhiran, JED; Williamson, K; Wilson, M | 1 |
Chang, J; He, H; Li, B; Li, Y; Miao, X; Peng, X; Tian, J; Wang, H; Wang, X; Yang, N; Ying, P; Zhong, R; Zhu, Y; Zou, D | 1 |
Chen, W; Fung, KM; He, Y; Houchen, CW; Li, M; Li, X; Liu, M; Luo, W; McNally, LR; Shi, X; Xu, C; Yang, J; Zhan, H; Zhang, C; Zhang, J; Zhang, Y; Zhou, Z | 1 |
Gao, ZX; Huang, CS; Huang, XT; Li, JH; Xu, QC; Yin, XY; Zhao, W; Zhu, XX | 1 |
Bai, R; Chen, R; Deng, J; Huang, J; Huang, X; Li, M; Lin, D; Liu, K; Pan, L; Su, J; Wei, L; Wu, G; Ye, Y; Zeng, L; Zhang, J; Zhang, S; Zheng, J; Zheng, Y; Zhuang, L | 1 |
Bai, R; Che, X; Chen, R; Fu, Z; Jia, W; Li, G; Li, M; Li, S; Lin, D; Liu, Z; Mai, D; Pan, L; Su, J; Tan, L; Tan, W; Wang, C; Wu, C; Xie, D; Xu, RH; Ye, H; Ye, Y; Zeng, MS; Zhang, J; Zhao, Q; Zheng, J; Zheng, S; Zheng, Y; Zuo, Z | 1 |
AlSaggar, M; Govindarajan, R; Griffin, J; Hung, SW; Mody, HR | 1 |
Avan, A; Crea, F; Danesi, R; Funel, N; Galvani, E; Giovannetti, E; Honeywell, RJ; Marquez, VE; Paolicchi, E; Peters, GJ | 1 |
11 other study(ies) available for adenosine and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Topics: 5'-Nucleotidase; Adenosine; Animals; Cancer Vaccines; Carcinoma, Pancreatic Ductal; Humans; Immunosuppression Therapy; Immunotherapy; Mice; Pancreatic Neoplasms; Tumor Microenvironment | 2023 |
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Topics: Adenosine; Animals; Carcinoma, Pancreatic Ductal; DEAD-box RNA Helicases; Gemcitabine; Humans; Lung Neoplasms; Methylation; Methyltransferases; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2023 |
METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.
Topics: Adenosine; Carcinoma, Pancreatic Ductal; Humans; Methyltransferases; Pancreatic Neoplasms; RNA, Double-Stranded; Tumor Microenvironment | 2023 |
Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.
Topics: Adenosine; Animals; Carcinoma, Pancreatic Ductal; Humans; Immunotherapy; Mice; Pancreatic Neoplasms; Tumor Microenvironment | 2023 |
Identification of genetic variants in m
Topics: 3' Untranslated Regions; Adenosine; Asian People; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Knockdown Techniques; Genetic Variation; Genotype; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; MicroRNAs; Pancreatic Neoplasms; Polymorphism, Single Nucleotide | 2021 |
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer.
Topics: Adenosine; Area Under Curve; Carcinoma, Pancreatic Ductal; Databases, Factual; DNA Copy Number Variations; Female; Humans; Immune Checkpoint Proteins; Immunotherapy; Male; Middle Aged; Pancreatic Neoplasms; Proportional Hazards Models; ROC Curve; Severity of Illness Index; Survival Analysis | 2021 |
HNRNPC impedes m
Topics: Adenosine; Alternative Splicing; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Transcription Factor TFIID | 2021 |
Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Prognosis; Protein Biosynthesis; RNA Splicing Factors; RNA, Long Noncoding; Survival Rate; Transcriptional Activation; Tumor Cells, Cultured; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Excessive miR-25-3p maturation via N
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Transformation, Neoplastic; Co-Repressor Proteins; Disease Progression; DNA Methylation; Epithelial Cells; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Male; Methyltransferases; MicroRNAs; Middle Aged; Nicotiana; Nuclear Proteins; Pancreatic Ducts; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Repressor Proteins; Ribosomal Protein S6 Kinases, 70-kDa; RNA-Binding Proteins; Smoke; Smoking; Up-Regulation | 2019 |
Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.
Topics: Adenosine; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Histones; Humans; Methyltransferases; Mice; MicroRNAs; Pancreatic Neoplasms; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2016 |
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.
Topics: AC133 Antigen; Adenosine; Antigens, CD; Antimetabolites, Antineoplastic; Apoptosis; Cadherins; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Movement; Deoxycytidine; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Membrane Transport Proteins; Pancreatic Neoplasms; Peptides; Polycomb Repressive Complex 2; Spheroids, Cellular; Tumor Cells, Cultured | 2012 |